Vir Biotechnology Inc [NASDAQ: VIR] traded at a high on Wednesday, posting a 58.17 gain after which it closed the day’ session at $12.48.
The results of the trading session contributed to over 39315098 shares changing hands. Over the past one week, the price volatility of Vir Biotechnology Inc stands at 9.33% while the volatility over the past one month is 6.19%.
The market cap for VIR stock reached $1.72 billion, with 136.71 million shares outstanding and 87.70 million shares in the current float. Compared to the average trading volume of 1.28M shares, VIR reached a trading volume of 39315098 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Vir Biotechnology Inc [VIR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VIR shares is $31.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VIR stock is a recommendation set at 1.56. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Vir Biotechnology Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 29, 2024. While these analysts kept the previous recommendation, BofA Securities dropped their target price from $23 to $14. The new note on the price target was released on September 08, 2023, representing the official price target for Vir Biotechnology Inc stock. Previously, the target price had yet another drop from $35 to $34, while JP Morgan kept a Overweight rating on VIR stock. On February 21, 2023, analysts increased their price target for VIR shares from 41 to 53.
The Average True Range (ATR) for Vir Biotechnology Inc is set at 0.87, with the Price to Sales ratio for VIR stock in the period of the last 12 months amounting to 21.86. The Price to Book ratio for the last quarter was 1.38, with the Price to Cash per share for the same quarter was set at 7.29.
How has VIR stock performed recently?
Vir Biotechnology Inc [VIR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 70.03. With this latest performance, VIR shares gained by 49.46% in over the last four-week period, additionally plugging by 49.10% over the last 6 months – not to mention a rise of 20.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VIR stock in for the last two-week period is set at 83.26, with the RSI for the last a single of trading hit 90.84, and the three-weeks RSI is set at 76.81 for Vir Biotechnology Inc [VIR]. The present Moving Average for the last 50 days of trading for this stock 8.09, while it was recorded at 8.62 for the last single week of trading, and 8.74 for the last 200 days.
Vir Biotechnology Inc [VIR]: Deeper insight into the fundamentals
Vir Biotechnology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.94 and a Current Ratio set at 8.94.
Earnings analysis for Vir Biotechnology Inc [VIR]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VIR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vir Biotechnology Inc go to 7.00%.
Insider trade positions for Vir Biotechnology Inc [VIR]
There are presently around $74.12%, or 84.14%% of VIR stock, in the hands of institutional investors. The top three institutional holders of VIR stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 16.68 million shares, which is approximately 12.3329%. BLACKROCK INC., holding 16.43 million shares of the stock with an approximate value of $$146.26 million in VIR stocks shares; and BLACKROCK INC., currently with $$114.36 million in VIR stock with ownership which is approximately 9.4982%.
